Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Barbituric Acid SCHEMBL38707 | 0.85 | — | — | |
| Barbituric Acid SCHEMBL4560317 | 0.85 | ALDH1A1 (0.55) | HSD17B10ALDH1A1CYP1A2HPGDHIF1A | |
| Barbituric Acid SCHEMBL9941322 | 0.85 | — | — | |
| Barbituric Acid SCHEMBL27648120 | 0.82 | ALDH1A1 (0.54) | HSD17B10ALDH1A1CYP1A2HPGDHIF1A | |
| Barbituric Acid SCHEMBL11674448 | 0.82 | ALDH1A1 (0.54) | HSD17B10ALDH1A1CYP1A2HPGDHIF1A | |
| Barbituric Acid SCHEMBL1972516 | 0.82 | ALDH1A1 (0.52) | HSD17B10ALDH1A1CYP1A2HPGDHIF1A | |
| Barbituric Acid SCHEMBL11379882 | 0.82 | ALDH1A1 (0.52) | HSD17B10ALDH1A1CYP1A2HPGDHIF1A | |
| Barbituric Acid SCHEMBL1974368 | 0.82 | ALDH1A1 (0.52) | HSD17B10ALDH1A1CYP1A2HPGDHIF1A | |
| Barbituric Acid SCHEMBL1973830 | 0.82 | ALDH1A1 (0.52) | HSD17B10ALDH1A1CYP1A2HPGDHIF1A | |
| Barbituric Acid SCHEMBL5924412 | 0.82 | ALDH1A1 (0.52) | HSD17B10ALDH1A1CYP1A2HPGDHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 484 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4684196-A1 | METHODS FOR ANTIGEN RETRIEVAL OF A FIXED SAMPLE FOR MULTIPLE APPLICATIONS | Resolve BioSciences GmbH (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-3804769-B1 | HYALURONIC ACID FILLER HAVING HIGH VISCOELASTICITY AND HIGH COHESIVENESS | LG CHEMICAL LTD (KR) | 2025-05-21 | — | — | EP | claimed |
| WO-2024193972-A1 | METHODS FOR ANTIGEN RETRIEVAL OF A FIXED SAMPLE FOR MULTIPLE APPLICATIONS | RESOLVE BIOSCIENCES GMBH (DE) | 2024-09-26 | — | — | WO | claimed |
| EP-4431531-A1 | METHOD FOR PREPARING COMPOSITION CONTAINING HYALURONIC ACID CROSSLINKED PRODUCT | Yoo Young Pharm Co., Ltd. (KR) | 2024-09-18 | — | — | EP | claimed |
| US-12002951-B2 | Buffer interlayers in membraneless high voltage batteries | URBAN ELECTRIC POWER INC. (US) | 2024-06-04 | — | — | US | claimed |
| US-20240047728-A1 | ELECTRODE-LESS, MEMBRANE-LESS HIGH VOLTAGE BATTERIES | URBAN ELECTRIC POWER INC. | 2024-02-08 | — | — | US | claimed |
| EP-3804770-B1 | HYALURONIC ACID FILLER HAVING HIGH LIFT CAPACITY AND LOW INJECTION FORCE | LG CHEMICAL LTD (KR) | 2023-12-06 | — | — | EP | claimed |
| WO-2023085832-A1 | METHOD FOR PREPARING COMPOSITION CONTAINING HYALURONIC ACID CROSSLINKED PRODUCT | 주식회사 유영제약 | 2023-05-19 | — | — | WO | claimed |
| US-11434206-B2 | Process for the preparation of diphenylpyrazine derivatives | HONOUR (R&D) (IN) | 2022-09-06 | — | — | US | claimed |
| WO-2022140603-A1 | ELECTRODE-LESS, MEMBRANE-LESS HIGH VOLTAGE BATTERIES | URBAN ELECTRIC POWER INC. (US) | 2022-06-30 | — | — | WO | claimed |
| EP-2470877-A1 | METHOD AND APPARATUS FOR ANTIGEN RETRIEVAL PROCESS | General Electric Company (US) | 2012-07-04 | — | — | EP | claimed |
| US-8067241-B2 | Method and apparatus for antigen retrieval process | GENERAL ELECTRIC COMPANY (US) | 2011-11-29 | — | — | US | claimed |
| WO-2011025442-A1 | METHOD AND APPARATUS FOR ANTIGEN RETRIEVAL PROCESS | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | WO | claimed |
| US-20110053171-A1 | METHOD AND APPARATUS FOR ANTIGEN RETRIEVAL PROCESS | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | US | claimed |
| CN-101081305-B | Liquid deodorant | KAO CORP | 2010-11-10 | — | — | CN | claimed |
| EP-1161589-B1 | LIQUID DEODORANT | KAO CORP (JP) | 2003-07-23 | — | — | EP | claimed |
| CN-1066480-C | Method for increasing injectability of reservoir polymer | PETROLEUM RECOVERY EFFICIENCY (CN) | 2001-05-30 | — | — | CN | claimed |
| CN-1144256-A | Method for increasing injectability of reservoir polymer | INST OF PETROLEUM RECOVERY EFF (CN) | 1997-03-05 | — | — | CN | claimed |
| CN-1128350-A | Compound salt system for determination of water-soluble superpolymer molecular weight | CHEMICAL INST CHINESE ACADEMY (CN) | 1996-08-07 | — | — | CN | claimed |
| US-4036823-A | Barbituric acid antigenic conjugates, their preparation, antibodies and use | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1977-07-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11434206-B2 | Process for the preparation of diphenylpyrazine derivatives | SELPLG, SELP, SPR | HSD17B10 3023/4885ALDH1A1 2680/4885CYP1A2 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.